Indefinite Delivery Contract HSHQDC14C00037

Award Date 6/9/14
Last Date to Order 6/12/15
Contracting Federal Agency
Office of Procurement Operations
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Cost Plus Fixed Fee
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to Pfenex Inc. The contract covers the advanced development of RPA563 and PX563L, with a single award and a total ceiling value of $144,092,373.11. The contract has an ultimate completion date of March 30, 2020, with an award date of August 14, 2015. No set-asides were used for this contract. The purpose of this contract is to support the...
The federal contract IDV award is a Blanket Purchase Agreement (BPA) master contract between the Defense Health Agency (DHA) and Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $8,000,000 and an ultimate completion date of January 24, 2030. Under this single-award BPA, Cepheid provides the DHA with reagents, testing kits, and consumable supplies for molecular diagnostic testing. Key products include GeneXpert diagnostic systems,...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of State's Office of Global Acquisitions, Acquisitions Management (A/GA/AM) on behalf of the Office of Global Operations, Logistics Operations and Supply Chain Management (A/GO/OPS/SCM) to BioFire Defense LLC, a manufacturer of in-vitro diagnostic products. The single-award BPA, valued up to $4,500,000, procures specialized laboratory testing supplies from BioFire Defense including FilmArray RP2.1 panel tests,...
This Other Transaction Agreement for Prototype awarded by the Joint PEO Chemical and Biological Defense, a U.S. Department of Defense agency, is for the development of an FDA-cleared diagnostic assay capable of differentiating between bacterial and viral infections in human clinical samples. The $21.3 million contract was awarded to Inflammatix, Inc., a small disadvantaged business based in Sunnyvale, California that specializes in molecular diagnostics and rapid point-of-care tests. Inflammatix...
This Other Transaction Agreement for Prototype is awarded by the Joint PEO Chemical and Biological Defense, a defense agency, to Biomeme, Inc., a self-certified small disadvantaged business and manufacturer of goods. The $30,112,812.75 IDV contract is for an FDA-cleared diagnostic assay able to differentiate between bacterial and viral infections in human clinical samples. Biomeme, a manufacturer of innovative molecular diagnostic solutions, has previously received federal contracts and...
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to the non-profit research institute SRI International. The $12.9 million contract, awarded on September 30, 2015 with a period of performance through November 30, 2020, aims to support "Biomarker Characterization and Confirmation for Rapid Clinical Diagnosis of Select Biothreat Agents." As the prime contractor,...
This indefinite delivery contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services, to the Lovelace Biomedical Research Institute. The $45,000,000 single-award contract runs through July 31, 2025 and is for the development of animal models to evaluate medical countermeasures for chemical, biological, radiological, and nuclear (CBRN) threats, pandemic influenza, and emerging...
The Department of Homeland Security (DHS) awarded a $2 billion multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract for COVID-19 Testing Solutions to provide test kits and managed testing services to support the department's mission and pandemic response efforts. The prime contractor, Federal Resources Supply Company, is a for-profit company that provides a range of goods and services, including personal protective equipment, safety supplies, and COVID-19 test kits, to...
This Indefinite Delivery Contract (IDC) was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency, to Southern Research Institute, a non-profit research organization. The contract has a ceiling value of $5,000,000 and a performance period ending on July 13, 2012. The contract aims to procure "OTHER SPECIAL STUDIES AND ANALYSES" for ASPR. Two task orders have been issued under this IDC to date, valued at $244,710 and $240,723...
This is a Blanket Purchase Agreement (BPA) awarded by the Uniformed Services University of the Health Sciences, a defense agency, to Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery. Meso Scale Diagnostics is a small business provider of assay development services, laboratory testing equipment, immunoassays, and multiplex assay kits to support biomedical research and testing for federal agencies. The BPA has a ceiling value of $1,000,000 and a period of performance through...

DIVISION: CHEMICAL BIOLOGICAL PPA: CBE DEFENSE R & D PROGRAM: BIOAGENT DETECTION PROJECT: POINT OF CARE DIAGNOSTICS ACTIVITY: RAPID DIAGNOSTICS PERFORMER: RAPID PATHOGEN SCREENING (RPS) APPROPRIATION YEAR: FY14 (46 FUNDS) BUDGET AUTHORITY: 3 YEAR R & D FUNDS PROJECT MANAGER: DAVID HODGE, 202-254-5813 FY14 (46) FUNDS ARE NO LONGER AVAILABLE FOR OBLIGATION AFTER SEPTEMBER 30, 2016. ALC: 70-08-1513 TAS: 70460800 DESCRIPTION: THE PURPOSE OF THIS TO DEPARTMENT OF HOMELAND SECURITY CONTRACT NO. HSHQDC-11-C-00131 WITH RAPID PATHOGEN SCREENING (RPS) IS TO PROVIDE ADDITIONAL FUNDING AND EXTEND THE PERIOD OF PERFORMANCE TO SUPPORT A PIVOTAL CLINICAL TRIAL OF FEBRIDX IN ACCORDANCE WITH THE ATTACHED STATEMENT OF WORK ENTITLED "BIOLOGICAL THREATS - RPS FEBRDX - VIRAL/BACTERIAL DIFFERENTIATION LFA". ACCORDINGLY, THE CONTRACT IS MODIFIED AS FOLLOWS: THIS MODIFICATION INCREASES THE TOTAL ESTIMATED AND FUNDED AMOUNTS OF THE CONTRACT FROM $1,473,007.00 BY $463,800.00 TO $1,936,807.00. AS A RESULT OF THIS MODIFICATION, THE PERIOD OF PERFORMANCE OF THIS CONTRACT IS HEREBY CHANGED FROM FEBRUARY 28, 1014 TO MARCH 31, 2015. THE DHS CONTRACTING OFFICER'S REPRESENTATIVE IS AS FOLLOWS: DAVID HODGE DEPARTMENT OF HOMELAND SECURITY SCIENCE AND TECHNOLOGY DIRECTORATE WASHINGTON, DC 20528 PHONE: 202-254-5813 EMAIL: DAVID.HODGE@HQ.DHS.GOV EXCEPT AS MODIFIED HEREIN, ALL OTHER TERMS AND CONDITIONS OF THE CONTRACT REMAIN IN FULL FORCE AND EFFECT.

Posted 6/9/14